|
|
Article: Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease.(Clinical report)
- Article from:
- Business Wire
- Article date:
- October 15, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Findings May Complement Current Clinical Practices for Assessing Risk of CHD
Findings Based on a Population-Based Prospective Study of Nearly 10,000 Individuals and Two Independent Case-Control Studies Involving Nearly 3,000 Individuals
ALAMEDA, Calif. -- Celera (NYSE:CRA), an Applera Corporation business, today announced the publication of results from the Atherosclerosis Risk in Communities (ARIC) study and two independent case-control studies describing the development of a Genetic Risk Score[TM] (GRS) based on five gene variants that predicts risk for coronary heart disease (CHD). These variant genes were KIF6, MYH15, PALLD, SNX19, and VAMP8. The ...